| The updated efficacy rate released late Wednesday was only three percentage points lower than the one announced days earlier. The new analysis also showed there were no severe cases of covid-19 in study volunteers who received the vaccine. But it may not resolve the challenges that the vaccine and the company face in the United States, as repeated missteps have sown confusion and distrust that may result in closer scrutiny of the data. | 
No comments:
Post a Comment